Pharmaceutical News

RSS

Misoprostol helps prevent postpartum haemorrhage after home births

Research brings together evidence about the potential for misoprostol to prevent bleeding after home births in low resource countries.

18 Dec 2012

Two cups of milk per day is enough to maintain adequate vitamin D levels for children

New research has answered one of the most common questions parents ask their doctors: How much milk should I be giving my children? The answer is two cups per day.

18 Dec 2012

PRSS3 enzyme linked to aggressive prostate cancer

Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic spread of the cancer.

18 Dec 2012

Physicians should not prescribe cognitive enhancers to healthy people

Physicians should not prescribe cognitive enhancers to healthy individuals, states a report being published today in the Canadian Medical Association Journal (CMAJ).

18 Dec 2012

Injecting LECT2 may protect against bacterial sepsis

Failure to launch an adequate immune response may be at the root of septic shock, according to a study published in The Journal of Experimental Medicine on December 17th.

18 Dec 2012

Experts warn banning thimerosal from use in vaccines would harm immunization campaigns in developing world

"A group of prominent doctors and public health experts warns in articles to be published Monday in the journal Pediatrics that banning thimerosal, a mercury compound used as a preservative in vaccines, would devastate public health efforts in developing countries," the New York Times reports.

17 Dec 2012

GSK receives FDA approval for FLUARIX QUADRIVALENT to treat seasonal flu

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX QUADRIVALENT (Influenza Virus Vaccine) for the immunisation of children (three years and older) and adults to help prevent disease caused by seasonal influenza (flu) virus subtypes A and type B contained in the vaccine.

17 Dec 2012

Maryland researchers launch groundbreaking study into spread of drug-resistant malaria in Burma

University of Maryland School of Medicine researchers have launched groundbreaking research into the spread of potentially deadly drug-resistant malaria in the developing Southeast Asian nation of Myanmar, also known as Burma.

17 Dec 2012

Lexicon receives FDA Fast Track status for development of LX1033 for irritable bowel syndrome

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast Track" status from the U.S. Food and Drug Administration for the development of LX1033, an orally-delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome (IBS-d).

17 Dec 2012

Allakos closes $32M Series A financing to develop antibody-based therapeutics

Allakos Inc. announced today that it has completed a $32 million Series A preferred stock financing led by Novo Ventures with participation from Alta Partners, RiverVest Venture Partners and the Roche Venture Fund. Peter Moldt , PhD., Partner at Novo Ventures, Robert Alexander , PhD., Director at Alta Partners and John McKearn PhD., Managing Director at RiverVest Venture Partners, will join the Board of Directors.

17 Dec 2012

ProMining Therapeutics, Roche to develop small molecule therapeutics for type 2 diabetes mellitus

ProMining Therapeutics, Ltd. today announced a new collaboration with Roche in the field of type 2 diabetes mellitus.

17 Dec 2012

Blocking single tiny blood vessel in the brain can harm neural tissue and even alter behavior

Blocking a single tiny blood vessel in the brain can harm neural tissue and even alter behavior, a new study from the University of California, San Diego has shown. But these consequences can be mitigated by a drug already in use, suggesting treatment that could slow the progress of dementia associated with cumulative damage to miniscule blood vessels that feed brain cells.

17 Dec 2012

Two hematology/oncology pharmacists to receive 2012 HOPA Foundation Research Award

The HOPA Foundation Board of Directors is pleased to announce the recipients of the 2012 HOPA Foundation Research Award, Dr. Kamakshi Rao for her project Improving & Defining the Impact & Value of Pharmacists in Stem Cell Transplant, and to Dr. Quan Li, for his project, In Vitro Stability of Erlotinib, Lapatinib and Imatinib in Common Compounding Vehicles.

15 Dec 2012

New issue of GHD-NET's Health & Foreign Policy Bulletin available online

The November 2012 issue of the Global Health Diplomacy Network's (GHD-NET) Health & Foreign Policy Bulletin is now available online.

15 Dec 2012

Accidental exposure to buprenorphine can make children extremely sick

Buprenorphine is a safe and effective drug for treating opioid addiction. But as the prescribed use of buprenorphine has dramatically increased in recent years, accidental exposure of children to the drug has risen sharply, placing them at risk for serious injury and in extremely rare cases even death, according to researchers at the Utah Poison Control Center (UPCC), U School of Medicine's Department of Family and Preventive Health, and the Utah Department of Health (UDOH).

15 Dec 2012

Researchers identify 125 genetic components in temozolomide-resistant, GBM-derived cell line

University of Pittsburgh Cancer Institute (UPCI) researchers have identified over 125 genetic components in a chemotherapy-resistant, brain tumor-derived cell line, which could offer new hope for drug treatment to destroy the cancer cells.

15 Dec 2012

Everolimus therapy might treat Myc-driven lymphoma

Drugs that are used in the clinic to treat some forms of breast and kidney cancer and that work by inhibiting the signaling molecule mTORC1 might have utility in treating some of the more than 15 percent of human cancers driven by alterations in the Myc gene, according to data from a preclinical study published in Cancer Discovery, a journal of the American Association for Cancer Research.

15 Dec 2012

Novartis receives FDA approval for Signifor injection to treat Cushing's disease

The U.S. Food and Drug Administration today approved Signifor (pasireotide diaspartate) injection for the treatment of Cushing's disease patients who cannot be helped through surgery.

15 Dec 2012

Bayer files radium-223 NDA with FDA for treatment of CRPC patients with bone metastases

Bayer HealthCare today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for radium Ra 223 dichloride (radium-223), an investigational compound for the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases.

15 Dec 2012

Iclusig gets FDA approval for two rare blood and bone marrow diseases

The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.

15 Dec 2012

Pharmaceutical News

Misoprostol helps prevent postpartum haemorrhage after home births

Two cups of milk per day is enough to maintain adequate vitamin D levels for children

PRSS3 enzyme linked to aggressive prostate cancer

Physicians should not prescribe cognitive enhancers to healthy people

Injecting LECT2 may protect against bacterial sepsis

Experts warn banning thimerosal from use in vaccines would harm immunization campaigns in developing world

GSK receives FDA approval for FLUARIX QUADRIVALENT to treat seasonal flu

Maryland researchers launch groundbreaking study into spread of drug-resistant malaria in Burma

Lexicon receives FDA Fast Track status for development of LX1033 for irritable bowel syndrome

Allakos closes $32M Series A financing to develop antibody-based therapeutics

ProMining Therapeutics, Roche to develop small molecule therapeutics for type 2 diabetes mellitus

Blocking single tiny blood vessel in the brain can harm neural tissue and even alter behavior

Two hematology/oncology pharmacists to receive 2012 HOPA Foundation Research Award

New issue of GHD-NET's Health & Foreign Policy Bulletin available online

Accidental exposure to buprenorphine can make children extremely sick

Researchers identify 125 genetic components in temozolomide-resistant, GBM-derived cell line

Everolimus therapy might treat Myc-driven lymphoma

Novartis receives FDA approval for Signifor injection to treat Cushing's disease

Bayer files radium-223 NDA with FDA for treatment of CRPC patients with bone metastases

Iclusig gets FDA approval for two rare blood and bone marrow diseases

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News